Glück Conviction Score™ ⓘ
IRWD
IRONWOOD PHARMACEUTICALS INC
ⓘ
Eingeschränkte Aussagekraft — erst 66 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Stark
Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
91,3
53 neu, 90 erhöht, 21,1M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 3.85 | -5.2 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 3.22 | +13.4 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 3.57 | EMA50: 3.72 | |
| MACD-Histogramm | Bullisch | 10 % | 0.020 | Bullisch | |
| RSI(14) | Neutral | 10 % | 50.7 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 56.8 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 16.0 | +DI: 24.3 / −DI: 22.9 | |
| Z-Score(60) | Neutral | 5 % | -0.24 | In Range | |
| 52W-Position | Neutral | 5 % | 63.5 % | Hoch 5.39 / Tief 0.62 | |
| Bollinger(20,2σ) | Neutral | 5 % | 60.8 % | Upper 4.00 / Mid 3.55 / Lower 3.10 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0018 | R²=0.01 / annualisiert +12.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | DENNER ALEXANDER J | Director | Open Market Sale | -6.725.000 | 3,05 | -20.511.250,00 | -1866,8% | |
| 2026-03-17 | DENNER ALEXANDER J | Director | Open Market Sale | -5.800 | 3,31 | -19.198,00 | -1,7% | |
| 2026-02-24 | Gaskins Tammi L | Officer, Chief Commercial Officer | Open Market Sale | -11.239 | 3,66 | -41.134,74 | -3,7% | |
| 2026-02-24 | MCCOURT Thomas A | Director, Officer, Chief Executive Officer | Open Market Sale | -103.526 | 3,66 | -378.905,16 | -34,5% | |
| 2026-02-24 | Silver Ronald | Officer, Principal Accounting Officer | Open Market Sale | -12.621 | 3,66 | -46.192,86 | -4,2% | |
| 2026-02-24 | Martini Gregory S. | Officer, Chief Financial Officer | Open Market Sale | -11.457 | 3,66 | -41.932,62 | -3,8% | |
| 2026-02-24 | John Minardo | Officer, Chief Legal Officer | Open Market Sale | -19.053 | 3,66 | -69.733,98 | -6,3% | |
| 2026-02-24 | Shetzline Michael | Officer, SVP, CMO, Head-Res&Drug | Open Market Sale | -17.012 | 3,66 | -62.263,92 | -5,7% | |
| 2026-02-23 | Gaskins Tammi L | Officer, Chief Commercial Officer | Open Market Sale | -10.287 | 3,81 | -39.193,47 | -3,6% | |
| 2026-02-23 | John Minardo | Officer, Chief Legal Officer | Open Market Sale | -17.439 | 3,81 | -66.442,59 | -6,0% | |
| 2026-02-23 | Shetzline Michael | Officer, SVP, CMO, Head-Res&Drug | Open Market Sale | -15.570 | 3,81 | -59.321,70 | -5,4% | |
| 2026-02-23 | Martini Gregory S. | Officer, Chief Financial Officer | Open Market Sale | -10.487 | 3,81 | -39.955,47 | -3,6% | |
| 2026-02-23 | Silver Ronald | Officer, Principal Accounting Officer | Open Market Sale | -11.552 | 3,81 | -44.013,12 | -4,0% | |
| 2026-02-23 | MCCOURT Thomas A | Director, Officer, Chief Executive Officer | Open Market Sale | -94.757 | 3,81 | -361.024,17 | -32,9% | |
| 2026-01-05 | Silver Ronald | Officer, Principal Accounting Officer | Open Market Sale | -35.416 | 4,60 | -162.913,60 | -14,8% | |
| 2025-11-17 | Gaskins Tammi L | Officer, Chief Commercial Officer | Open Market Sale | -6.016 | 3,32 | -19.973,12 | -1,8% | |
| 2025-08-11 | Martini Gregory S. | Officer, Chief Financial Officer | Open Market Sale | -1.265 | 0,84 | -1.062,60 | -0,1% | |
| 2025-08-11 | John Minardo | Officer, Chief Legal Officer | Open Market Sale | -7.754 | 0,84 | -6.513,36 | -0,6% | |
| 2025-08-11 | Gaskins Tammi L | Officer, Chief Commercial Officer | Open Market Sale | -1.316 | 0,84 | -1.105,44 | -0,1% | |
| 2025-08-11 | Silver Ronald | Officer, Principal Accounting Officer | Open Market Sale | -2.846 | 0,84 | -2.390,64 | -0,2% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Context Capital Management, LLC | 59.619.000 | 42.119.000 | 17.500.000 | 58.113.620 | Aufgestockt | +41,5% | |
| VANGUARD GROUP INC | 15.958.196 | 0 | 15.958.196 | 53.779.120 | Neu | +100,0% | |
| ARMISTICE CAPITAL, LLC | 15.028.000 | 16.025.000 | -997.000 | 52.748.280 | Reduziert | -6,2% | |
| BRAIDWELL LP | 53.405.000 | 0 | 53.405.000 | 50.467.725 | Neu | +100,0% | |
| BlackRock, Inc. | 13.362.930 | 12.784.806 | 578.124 | 46.903.884 | Aufgestockt | +4,5% | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46.942.000 | 46.942.000 | 0 | 46.120.515 | Unverändert | 0,0% | |
| JPMORGAN CHASE & CO | 46.942.000 | 515.607 | 46.426.393 | 46.120.515 | Aufgestockt | +9004,2% | |
| UBS Group AG | 14.703.545 | 11.710.863 | 2.992.682 | 45.084.213 | Aufgestockt | +25,6% | |
| Sarissa Capital Management LP | 9.188.635 | 15.919.435 | -6.730.800 | 32.252.109 | Reduziert | -42,3% | |
| BANK OF AMERICA CORP /DE/ | 8.682.907 | 11.521.660 | -2.838.753 | 30.477.004 | Reduziert | -24,6% | |
| D. E. Shaw & Co., Inc. | 29.197.938 | 11.767.446 | 17.430.492 | 28.918.178 | Aufgestockt | +148,1% | |
| RENAISSANCE TECHNOLOGIES LLC | 8.061.073 | 8.204.973 | -143.900 | 28.294.366 | Reduziert | -1,8% | |
| AQR CAPITAL MANAGEMENT LLC | 7.535.080 | 4.723.531 | 2.811.549 | 26.448.131 | Aufgestockt | +59,5% | |
| STATE STREET CORP | 7.456.944 | 4.411.222 | 3.045.722 | 26.173.873 | Aufgestockt | +69,0% | |
| DeepCurrents Investment Group LLC | 25.500.000 | 25.500.000 | 0 | 25.105.998 | Unverändert | 0,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.097.454 | 0 | 6.097.454 | 21.402.064 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 5.848.276 | 2.853.205 | 2.995.071 | 20.527.449 | Aufgestockt | +105,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 18.405.000 | 65.156 | 18.339.844 | 18.045.734 | Aufgestockt | +28147,6% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.737.857 | 4.975.939 | -238.082 | 16.629.878 | Reduziert | -4,8% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4.543.522 | 3.623.534 | 919.988 | 15.950.694 | Aufgestockt | +25,4% | |
| MARSHALL WACE, LLP | 4.525.064 | 4.424.002 | 101.062 | 15.882.975 | Aufgestockt | +2,3% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3.632.477 | 2.759.667 | 872.810 | 12.749.994 | Aufgestockt | +31,6% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.397.242 | 412.061 | 2.985.181 | 11.924.319 | Aufgestockt | +724,5% | |
| FEDERATED HERMES, INC. | 3.348.806 | 3.318.137 | 30.669 | 11.754.309 | Aufgestockt | +0,9% | |
| TWO SIGMA ADVISERS, LP | 3.140.100 | 0 | 3.140.100 | 10.582.137 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 2.690.634 | 1.275.315 | 1.415.319 | 9.444.125 | Aufgestockt | +111,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2.082.055 | 330.836 | 1.751.219 | 7.306.566 | Aufgestockt | +529,3% | |
| Chicago Capital Management, LLC | 7.000 | 4.000 | 3.000 | 6.908.417 | Aufgestockt | +75,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.900.757 | 515.299 | 1.385.458 | 6.671.657 | Aufgestockt | +268,9% | |
| Connor, Clark & Lunn Investment Management Ltd. | 1.835.424 | 1.990.927 | -155.503 | 6.442.338 | Reduziert | -7,8% | |
| Qube Research & Technologies Ltd | 1.590.081 | 1.681.229 | -91.148 | 5.581.184 | Reduziert | -5,4% | |
| NORTHERN TRUST CORP | 1.265.842 | 1.233.685 | 32.157 | 4.443.105 | Aufgestockt | +2,6% | |
| Hillsdale Investment Management Inc. | 1.236.628 | 1.156.378 | 80.250 | 4.340.565 | Aufgestockt | +6,9% | |
| DEUTSCHE BANK AG\ | 1.124.989 | 1.109.924 | 15.065 | 3.948.711 | Aufgestockt | +1,4% | |
| MORGAN STANLEY | 824.819 | 739.685 | 85.134 | 2.895.115 | Aufgestockt | +11,5% | |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3.000.000 | 0 | 3.000.000 | 2.837.126 | Neu | +100,0% | |
| FMR LLC | 790.386 | 686.737 | 103.649 | 2.774.254 | Aufgestockt | +15,1% | |
| RAYMOND JAMES FINANCIAL INC | 763.955 | 869.826 | -105.871 | 2.681.482 | Reduziert | -12,2% | |
| FRANKLIN RESOURCES INC | 744.638 | 385.583 | 359.055 | 2.613.680 | Aufgestockt | +93,1% | |
| IEQ CAPITAL, LLC | 742.723 | 633.260 | 109.463 | 2.606.958 | Aufgestockt | +17,3% | |
| SEI INVESTMENTS CO | 742.548 | 673.862 | 68.686 | 2.606.340 | Aufgestockt | +10,2% | |
| VICTORY CAPITAL MANAGEMENT INC | 713.187 | 18.042 | 695.145 | 2.503.286 | Aufgestockt | +3852,9% | |
| JANE STREET GROUP, LLC | 661.847 | 2.836.462 | -2.174.615 | 2.323.082 | Reduziert | -76,7% | |
| DIADEMA PARTNERS LP | 683.611 | 0 | 683.611 | 2.303.769 | Neu | +100,0% | |
| Exome Asset Management LLC | 648.532 | 0 | 648.532 | 2.185.553 | Neu | +100,0% | |
| STATE OF WISCONSIN INVESTMENT BOARD | 598.159 | 180.040 | 418.119 | 2.099.538 | Aufgestockt | +232,2% | |
| MACKENZIE FINANCIAL CORP | 560.034 | 11.544 | 548.490 | 1.965.719 | Aufgestockt | +4751,3% | |
| Integrated Quantitative Investments LLC | 552.104 | 102.654 | 449.450 | 1.937.885 | Aufgestockt | +437,8% | |
| Invesco Ltd. | 547.360 | 449.219 | 98.141 | 1.921.234 | Aufgestockt | +21,8% | |
| Man Group plc | 540.864 | 47.659 | 493.205 | 1.898.433 | Aufgestockt | +1034,9% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| Context Capital Management, LLC | 59.619.000 | 42.119.000 | +41,5% | 58.113.620 | 7,95 |
| ARMISTICE CAPITAL, LLC | 15.028.000 | 16.025.000 | -6,2% | 52.748.280 | 7,21 |
| BlackRock, Inc. | 13.362.930 | 12.784.806 | +4,5% | 46.903.884 | 6,41 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46.942.000 | 46.942.000 | 0,0% | 46.120.515 | 6,31 |
| UBS Group AG | 14.703.545 | 11.710.863 | +25,6% | 45.084.213 | 6,17 |
| Sarissa Capital Management LP | 9.188.635 | 15.919.435 | -42,3% | 32.252.109 | 4,41 |
| BANK OF AMERICA CORP /DE/ | 8.682.907 | 11.521.660 | -24,6% | 30.477.004 | 4,17 |
| D. E. Shaw & Co., Inc. | 29.197.938 | 11.767.446 | +148,1% | 28.918.178 | 3,95 |
| RENAISSANCE TECHNOLOGIES LLC | 8.061.073 | 8.204.973 | -1,8% | 28.294.366 | 3,87 |
| AQR CAPITAL MANAGEMENT LLC | 7.535.080 | 4.723.531 | +59,5% | 26.448.131 | 3,62 |
| STATE STREET CORP | 7.456.944 | 4.411.222 | +69,0% | 26.173.873 | 3,58 |
| DeepCurrents Investment Group LLC | 25.500.000 | 25.500.000 | 0,0% | 25.105.998 | 3,43 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.097.454 | 0 | +100,0% | 21.402.064 | 2,93 |
| TWO SIGMA INVESTMENTS, LP | 5.848.276 | 2.853.205 | +105,0% | 20.527.449 | 2,81 |
| BALYASNY ASSET MANAGEMENT L.P. | 18.405.000 | 65.156 | +28147,6% | 18.045.734 | 2,47 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.737.857 | 4.975.939 | -4,8% | 16.629.878 | 2,27 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.543.522 | 3.623.534 | +25,4% | 15.950.694 | 2,18 |
| MARSHALL WACE, LLP | 4.525.064 | 4.424.002 | +2,3% | 15.882.975 | 2,17 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3.632.477 | 2.759.667 | +31,6% | 12.749.994 | 1,74 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.397.242 | 412.061 | +724,5% | 11.924.319 | 1,63 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 227 | 407,8 | 830 |
| 31.12.2025 | ✓ | 208 | 351,4 | 717 |
| 30.09.2025 | ✓ | 173 | 344,4 | 396 |
| 30.06.2025 | ✓ | 162 | 325,5 | 274 |
| 31.03.2025 | ✓ | 206 | 346,6 | 431 |
| 31.12.2024 | ✓ | 230 | 347,1 | 960 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Hillsdale Investment Management Inc. | 1.156.378 | 3.896.994 |
| Chicago Capital Management, LLC | 4.000 | 3.792.667 |
| LAZARD ASSET MANAGEMENT LLC | 1.000.445 | 3.371.500 |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3.000.000 | 2.837.126 |
| DIADEMA PARTNERS LP | 683.611 | 2.303.769 |
| Exome Asset Management LLC | 648.532 | 2.185.553 |
| Amundi | 642.830 | 2.166.337 |
| Walleye Capital LLC | 527.936 | 1.779.144 |
| WELLINGTON MANAGEMENT GROUP LLP | 503.942 | 1.698.284 |
| Range Financial Group LLC | 426.095 | 1.435.940 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Context Capital Management, LLC | 42.119.000 | 42.090.923 | +149912.5 % | 39.802.455 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46.942.000 | 16.562.748 | +54.5 % | 44.735.726 |
| D. E. Shaw & Co., Inc. | 11.767.446 | 1.845.176 | +18.6 % | 11.422.518 |
| MARSHALL WACE, LLP | 4.424.002 | 1.279.863 | +40.7 % | 14.908.888 |
| STATE STREET CORP | 4.411.222 | 1.254.915 | +39.8 % | 14.865.818 |
| FEDERATED HERMES, INC. | 3.318.137 | 1.161.033 | +53.8 % | 11.182.122 |
| RAYMOND JAMES FINANCIAL INC | 869.826 | 854.780 | +5681.1 % | 2.931.314 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.759.667 | 839.137 | +43.7 % | 9.300.078 |
| BlackRock, Inc. | 12.784.806 | 722.248 | +6.0 % | 43.084.796 |
| JANE STREET GROUP, LLC | 2.836.462 | 515.367 | +22.2 % | 9.558.877 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BRAIDWELL LP | 53.405.000 | -28.735.000 | -35.0 % | 50.467.725 |
| DeepCurrents Investment Group LLC | 25.500.000 | -1.500.000 | -5.6 % | 24.173.592 |
| Qube Research & Technologies Ltd | 1.681.229 | -1.125.681 | -40.1 % | 5.665.742 |
| AQR CAPITAL MANAGEMENT LLC | 4.723.531 | -655.004 | -12.2 % | 15.918.299 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 634.331 | -495.721 | -43.9 % | 951.498 |
| DEUTSCHE BANK AG\ | 1.109.924 | -417.305 | -27.3 % | 3.740.444 |
| CITADEL ADVISORS LLC | 371.769 | -310.677 | -45.5 % | 1.252.861 |
| UBS Group AG | 11.710.863 | -301.121 | -2.5 % | 39.465.609 |
| State of Wyoming | 157.325 | -205.082 | -56.6 % | 530.185 |
| TWO SIGMA ADVISERS, LP | 3.140.100 | -176.400 | -5.3 % | 10.582.137 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Armistice Capital, LLC | Passiv (13G/A) | 9,22 % | 15.028.000 | -0,63 pp | |
| 15.05.2026 | Steven Boyd | Passiv (13G/A) | 9,22 % | 15.028.000 | -0,63 pp | |
| 14.05.2026 | Renaissance Technologies Holdings Corporation | Passiv (13G/A) | 4,90 % | 8.061.073 | -0,47 pp | |
| 14.05.2026 | Renaissance Technologies LLC | Passiv (13G/A) | 4,90 % | 8.061.073 | -0,47 pp | |
| 27.04.2026 | BANK OF AMERICA CORP /DE/ | Passiv (13G/A) | 6,10 % | 9.962.355 | -1,30 pp | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,01 pp | |
| 19.03.2026 | Sarissa Capital Management LP | Aktivist (13D/A) | 5,60 % | 9.188.635 | -3,70 pp | |
| 19.03.2026 | Alexander J. Denner | Aktivist (13D/A) | 5,80 % | 9.444.944 | Neu | |
| 17.02.2026 | Armistice Capital, LLC | Passiv (13G/A) | 9,85 % | 16.025.000 | -0,09 pp | |
| 17.02.2026 | Steven Boyd | Passiv (13G/A) | 9,85 % | 16.025.000 | -0,09 pp | |
| 14.11.2025 | BANK OF AMERICA CORP /DE/ | Passiv (13G) | 7,40 % | 11.986.267 | Neu | |
| 12.11.2025 | Barclays PLC | Passiv (13G/A) | 1,95 % | 3.167.713 | -4,93 pp | |
| 15.08.2025 | Armistice Capital, LLC | Passiv (13G/A) | 9,94 % | 16.150.000 | +1,47 pp | |
| 15.08.2025 | Steven Boyd | Passiv (13G/A) | 9,94 % | 16.150.000 | +1,47 pp | |
| 12.08.2025 | Barclays PLC | Passiv (13G) | 6,88 % | 11.133.857 | Neu | |
| 07.07.2025 | The Vanguard Group | Passiv (13G/A) | 10,01 % | 16.202.129 | +0,21 pp | |
| 15.05.2025 | Armistice Capital, LLC | Passiv (13G/A) | 8,47 % | 13.700.000 | +2,55 pp | |
| 15.05.2025 | Steven Boyd | Passiv (13G/A) | 8,47 % | 13.700.000 | +2,55 pp | |
| 13.05.2025 | STATE STREET CORPORATION | Passiv (13G) | 2,20 % | 3.498.289 | -3,00 pp | |
| 02.05.2025 | Joe M. Thomson | Passiv (13G/A) | 1,12 % | 1.789.098 | -6,20 pp | |
| 02.05.2025 | Pacer US Small Cap Cash Cows Growth Leaders ETF | Passiv (13G/A) | Ausstieg | 0 | -0,01 pp | |
| 02.05.2025 | Pacer US Small Cap Cash Cows ETF | Passiv (13G/A) | 1,12 % | 1.789.098 | -6,19 pp | |
| 02.05.2025 | Pacer Advisors, Inc. | Passiv (13G/A) | 1,12 % | 1.789.098 | -6,20 pp | |
| 02.05.2025 | Pacer US Small Cap Cash Cows Growth Leaders ETF | Passiv (13G) | 0,01 % | 19.266 | Neu | |
| 02.05.2025 | Joe M. Thomson | Passiv (13G) | 7,32 % | 11.730.771 | Neu | |
| 02.05.2025 | Pacer Advisors, Inc. | Passiv (13G) | 7,32 % | 11.730.771 | Neu | |
| 02.05.2025 | Pacer US Small Cap Cash Cows ETF | Passiv (13G) | 7,31 % | 11.711.505 | Neu | |
| 30.04.2025 | The Vanguard Group | Passiv (13G/A) | 9,80 % | 15.696.161 | -2,40 pp | |
| 07.03.2025 | BlackRock, Inc. | Passiv (13G/A) | 7,10 % | 11.284.399 | Neu | |
| 14.02.2025 | Armistice Capital, LLC | Passiv (13G/A) | 5,92 % | 9.468.000 | +0,79 pp | |
| 14.02.2025 | Steven Boyd | Passiv (13G/A) | 5,92 % | 9.468.000 | +0,79 pp | |
| 05.02.2025 | STATE STREET CORPORATION | Passiv (13G) | 5,20 % | 8.328.817 | -1,00 pp | |
| 31.01.2025 | The Vanguard Group | Passiv (13G/A) | 12,20 % | 19.538.555 | -1,59 pp | |
| 14.11.2024 | Steven Boyd | Passiv (13G) | 5,13 % | 8.200.000 | Neu | |
| 14.11.2024 | Armistice Capital, LLC | Passiv (13G) | 5,13 % | 8.200.000 | Neu | |
| 13.11.2024 | Renaissance Technologies Holdings Corporation | Passiv (13G) | 5,37 % | 8.597.198 | Neu | |
| 13.11.2024 | Renaissance Technologies LLC | Passiv (13G) | 5,37 % | 8.597.198 | Neu | |
| 12.11.2024 | The Vanguard Group | Passiv (13G/A) | 13,79 % | 22.038.097 | 0,00 pp | |
| 08.11.2024 | . BlackRock, Inc. | Passiv (13G/A) | 14,30 % | 22.918.324 | 0,00 pp | |
| 04.11.2024 | The Vanguard Group | Passiv (13G/A) | 13,79 % | 22.038.097 | +3,52 pp |
Stammdaten
Ironwood Pharmaceuticals, Inc., ein Gesundheitsunternehmen, konzentriert sich auf die Entwicklung und Vermarktung von gastrointestinalen (GI) Produkten. Das Unternehmen vertreibt Linaclotid, einen Guanylat-Cyclase-Typ-C-Agonisten zur Behandlung von Erwachsenen mit Reizdarmsyndrom mit Verstopfung (IBS-C) oder chronischer idiopathischer Verstopfung (CIC) unter dem Namen LINZESS in den Vereinigten Staaten und Mexiko, sowie unter dem Namen CONSTELLA in Kanada und der Europäischen Union. Das Unternehmen entwickelt auch IW-3300, einen GC-C-Agonisten zur Behandlung von viszeralen Schmerzsyndromen, einschließlich interstitieller Zystitis/Blasenschmerzsyndrom und Endometriose, sowie CNP-104, ein Immunnonopartikel zur Behandlung von biliärer Cholangitis. Das Unternehmen hat strategische Partnerschaften mit AbbVie Inc., AstraZeneca AB und Astellas Pharma Inc. für die Entwicklung und Vermarktung von Linaclotid. Das Unternehmen war ehemals als Microbia, Inc. bekannt und änderte seinen Namen im April 2008 in Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. wurde 1998 gegründet und hat seinen Hauptsitz in Boston, Massachusetts.
Unternehmen & Branche
| Name | IRONWOOD PHARMACEUTICALS INC |
|---|---|
| Ticker | IRWD |
| CIK | 0001446847 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 46333X108 |
|---|---|
| ISIN | US46333X1081 |
| Typ | Common Stock |
| Marktkapitalisierung | 597,6 Mio. USD |
| KGV (P/E) | 24,43 |
| Beta | 0,28 |
Bewertung
| KUV (P/S) | 2,02 vs. 4,57 (2021) ▼ |
|---|---|
| EV/EBITDA | 4,0 vs. 7,5 (2021) ▼ |
| FCF-Rendite | 21,3 % vs. 13,8 % (2021) ▲ |
Qualität & Bilanz
| Operative Marge | 33,3 % vs. 56,1 % (2021) ▼ |
|---|---|
| Nettomarge | 8,1 % vs. 127,7 % (2021) ▼ |
| Nettoverschuldung/EBITDA | -2,0 vs. -0,6 (2021) ▼ |
| Zinsdeckungsgrad | 3,0 vs. 7,5 (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 3,12 | 2,93 | – | – | – | |
| KUV (P/S) | 4,57 | 4,65 | 4,04 | 2,02 | 1,86 | |
| EV/EBITDA | 7,5 | 6,6 | – | 6,7 | 3,5 | |
| FCF-Rendite | 13,8 % | 14,3 % | 10,2 % | 14,6 % | 23,1 % | |
| Buyback-Rendite | 1,3 % | 6,6 % | – | – | – | |
| Qualität & Bilanz | ||||||
| Operative Marge | 56,1 % | 61,0 % | -213,5 % | 26,5 % | 33,3 % | |
| Nettomarge | 127,7 % | 42,6 % | -226,4 % | 0,3 % | 8,1 % | |
| ROIC | 48,9 % | 16,4 % | – | – | – | |
| Nettoverschuldung/EBITDA | -0,6 | -1,0 | – | -0,8 | -2,0 | |
| Zinsdeckungsgrad | 7,5 | 32,9 | -43,7 | 2,8 | 3,0 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 106.506.000 | 40.773.000 | 0,24 | 434.566.000 | -217.144.000 |
| 2025-12-31 | 10-K | 296.151.000 | 24.017.000 | 0,15 | 396.901.000 | -261.835.000 |
| 2025-09-30 | 10-Q | 122.060.000 | 40.080.000 | 0,23 | 396.062.000 | -264.157.000 |
| 2025-06-30 | 10-Q | 85.239.000 | 23.599.000 | 0,14 | 342.946.000 | -308.162.000 |
| 2025-03-31 | 10-Q | 41.143.000 | -37.386.000 | -0,23 | 327.213.000 | -334.053.000 |
| 2024-12-31 | 10-K | 351.410.000 | 880.000 | 0,01 | 350.908.000 | -301.335.000 |
| 2024-09-30 | 10-Q | 91.592.000 | 3.646.000 | 0,02 | 389.519.000 | -311.334.000 |
| 2024-06-30 | 10-Q | 94.396.000 | -860.000 | -0,01 | 395.620.000 | -321.727.000 |
| 2024-03-31 | 10-Q | 74.877.000 | -4.162.000 | -0,03 | 438.819.000 | -330.518.000 |
| 2023-12-31 | 10-K | 442.735.000 | -1.002.239.000 | -6,45 | 471.073.000 | -346.295.000 |
| 2023-09-30 | 10-Q | 113.739.000 | 15.321.000 | 0,09 | 524.063.000 | -323.216.000 |
| 2023-06-30 | 10-Q | 107.382.000 | -1.062.187.000 | -6,84 | 603.220.000 | -345.704.000 |
| 2023-03-31 | 10-Q | 104.061.000 | 45.714.000 | 0,25 | 1.155.277.000 | 706.852.000 |
| 2022-12-31 | 10-K | 410.596.000 | 175.065.000 | 0,96 | 1.100.519.000 | 652.378.000 |
| 2022-09-30 | 10-Q | 108.637.000 | 50.317.000 | 0,28 | 1.040.344.000 | 591.063.000 |
| 2022-06-30 | 10-Q | 97.231.000 | 37.080.000 | 0,21 | 975.690.000 | 532.883.000 |
| 2022-03-31 | 10-Q | 97.529.000 | 38.801.000 | 0,21 | 1.083.381.000 | 517.783.000 |
| 2021-12-31 | 10-K | 413.753.000 | 528.448.000 | 3,21 | 1.126.927.000 | 605.911.000 |
| 2021-09-30 | 10-Q | 103.747.000 | 55.845.000 | 0,34 | 1.079.371.000 | 579.941.000 |
| 2021-06-30 | 10-Q | 104.031.000 | 391.303.000 | 2,39 | 1.007.218.000 | 511.756.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Collaborative Arrangements | 296,2 Mio. | 351,4 Mio. | 442,7 Mio. | 410,6 Mio. | 412,8 Mio. | 100,0 % | -15,7% | |
| Collaborative Arrangement Other Agreements | 87.000 | 734.000 | 2,5 Mio. | 1,8 Mio. | 1,8 Mio. | 0,0 % | -88,1% | |
| Active Pharmaceutical Ingredient | – | – | – | – | 969.000 | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 106,5 Mio. USD | 0,24 |
| Q3 2025 | 30.09.2025 | 10.11.2025 | 122,1 Mio. USD | 0,23 |
| Q2 2025 | 30.06.2025 | 11.08.2025 | 85,2 Mio. USD | 0,14 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | 41,1 Mio. USD | -0,23 |
| Q3 2024 | 30.09.2024 | 10.11.2025 | 91,6 Mio. USD | 0,02 |
| Q2 2024 | 30.06.2024 | 11.08.2025 | 94,4 Mio. USD | -0,01 |
| Q1 2024 | 31.03.2024 | 12.05.2025 | 74,9 Mio. USD | -0,03 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | 113,7 Mio. USD | 0,09 |
| Q2 2023 | 30.06.2023 | 08.08.2024 | 107,4 Mio. USD | -6,84 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 10.11.2025 | 10-Q | 30.09.2025 | 41 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 31.03.2025 | 10-K | 31.12.2024 | 90 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 16.02.2024 | 10-K | 31.12.2023 | 47 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 16.02.2023 | 10-K | 31.12.2022 | 47 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 18.02.2022 | 10-K | 31.12.2021 | 49 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 17.02.2021 | 10-K | 31.12.2020 | 48 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (21.05.2026)
HOCH Abgang Schlüsselpersonen (13.05.2026)
HOCH Abgang Schlüsselpersonen (21.05.2026)
HOCH Abgang Schlüsselpersonen (13.05.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 21.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ¨ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 29.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | differ materially from these estimates. Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 05.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 20.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 01.12.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.02.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.11.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.04.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-22 | 74.314 | 4,07 | 302.458 |
| 2026-04-21 | 1.171 | 4,42 | 5.176 |
| 2026-04-07 | 4.292 | 3,53 | 15.151 |
| 2026-04-01 | 2.057 | 3,51 | 7.220 |
| 2026-03-11 | 12.573 | 3,70 | 46.520 |
| 2026-03-02 | 3.176 | 3,42 | 10.862 |
| 2026-02-26 | 1.083 | 3,36 | 3.639 |
| 2026-02-19 | 71 | 4,78 | 339 |
| 2026-02-02 | 923 | 4,89 | 4.513 |
| 2026-01-28 | 436 | 5,14 | 2.241 |
| 2026-01-21 | 249 | 4,58 | 1.140 |
| 2026-01-16 | 380 | 4,52 | 1.718 |
| 2026-01-15 | 3.835 | 4,54 | 17.411 |